P
Peter Arner
Researcher at Karolinska Institutet
Publications - 565
Citations - 56932
Peter Arner is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Adipose tissue & Lipolysis. The author has an hindex of 114, co-authored 553 publications receiving 52710 citations. Previous affiliations of Peter Arner include Karolinska University Hospital & Bristol-Myers Squibb.
Papers
More filters
Journal ArticleDOI
Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals.
Rachel M. Fisher,Per Eriksson,Johan Hoffstedt,G S Hotamisligil,Anders Thörne,Mikael Rydén,Anders Hamsten,Peter Arner +7 more
TL;DR: Investigation of adipose tissue FABPs could further the understanding of the role of fatty acids in the insulin resistance syndrome, and the ALBP/KLBP ratio is greater in subcutaneous than visceral adipOSE tissue in lean as well as in obese subjects.
Journal ArticleDOI
Macronutrient-specific effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans.
Katrine Grau,Torben Hansen,Claus Holst,Arne Astrup,W. H. M. Saris,Peter Arner,Stephan Rössner,Ian A. Macdonald,Joseph F. Polak,J.-M. Oppert,Dominique Langin,José Alfredo Martínez,O. Pedersen,T I A Sørensen +13 more
TL;DR: The FTO rs9939609 may interact with the macronutrient composition in weight loss diets in various ways; carriers of the A allele on LF diet appear to have a lower risk for drop out, and TT individuals have a smaller decrease in REE and greater decrease in HOMA-β and HomA-IR on LF than on HF diet.
Journal ArticleDOI
The beta 3-adrenergic receptor : a cause and cure of obesity ?
TL;DR: The adrenergic system plays a major part in controlling energy expenditure and catecholamines mobilize energy-rich lipids by stimulating lipolysis in fat cells and thermogenesis in brown adipose tissue and skeletal muscle.
Journal ArticleDOI
Glucocorticoid Receptor Messenger Ribonucleic Acid in Different Regions of Human Adipose Tissue
TL;DR: Variations in GR mRNA levels between sexes and body regions may explain the well known sex and tissue differences in effects of glucocorticoids on human adipose tissue.
Journal ArticleDOI
Free fatty acids - do they play a central role in type 2 diabetes?
TL;DR: In the overall view of this complex disease process, it is becoming increasingly apparent that reducing FFA levels is an important goal in the management of patients with type 2 diabetes.